RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 75 filers reported holding RELMADA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $141,306 | +21.1% | 47,102 | -0.7% | 0.00% | – |
| Q2 2023 | $116,728 | -75.4% | 47,450 | -77.4% | 0.00% | – |
| Q1 2023 | $474,579 | -40.4% | 209,991 | -8.0% | 0.00% | – |
| Q4 2022 | $796,938 | -91.4% | 228,349 | -9.2% | 0.00% | -100.0% |
| Q3 2022 | $9,310,000 | +96.0% | 251,477 | +0.6% | 0.00% | +100.0% |
| Q2 2022 | $4,749,000 | -28.4% | 250,071 | +1.8% | 0.00% | 0.0% |
| Q1 2022 | $6,630,000 | +69.2% | 245,636 | +41.2% | 0.00% | 0.0% |
| Q4 2021 | $3,919,000 | -8.4% | 173,932 | +6.6% | 0.00% | 0.0% |
| Q3 2021 | $4,278,000 | -14.5% | 163,205 | +4.4% | 0.00% | 0.0% |
| Q2 2021 | $5,006,000 | -12.6% | 156,398 | -3.9% | 0.00% | 0.0% |
| Q1 2021 | $5,729,000 | +3.3% | 162,694 | -5.9% | 0.00% | 0.0% |
| Q4 2020 | $5,548,000 | -16.7% | 172,968 | -2.3% | 0.00% | 0.0% |
| Q3 2020 | $6,659,000 | -18.4% | 177,018 | -2.9% | 0.00% | -50.0% |
| Q2 2020 | $8,159,000 | +798.6% | 182,323 | +585.1% | 0.00% | – |
| Q1 2020 | $908,000 | -4.1% | 26,613 | +9.6% | 0.00% | – |
| Q4 2019 | $947,000 | – | 24,281 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Guild Investment Management, Inc. | 205,300 | $615,900 | 1.03% |
| Deep Track Capital, LP | 2,837,818 | $8,513,454 | 0.33% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 974,082 | $2,922,246 | 0.23% |
| apricus wealth, LLC | 77,362 | $239,822 | 0.21% |
| Palo Alto Investors LP | 732,400 | $2,197,200 | 0.21% |
| RTW INVESTMENTS, LP | 2,131,835 | $6,395,505 | 0.14% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 100,000 | $300,000 | 0.09% |
| AdvisorShares Investments LLC | 112,908 | $338,724 | 0.09% |
| Savior LLC | 3,500 | $10,500 | 0.07% |
| Spotlight Asset Group, Inc. | 20,000 | $60,000 | 0.05% |